Compare MCHX & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCHX | YI |
|---|---|---|
| Founded | 2003 | 2010 |
| Country | United States | China |
| Employees | N/A | 1238 |
| Industry | Business Services | Retail-Drug Stores and Proprietary Stores |
| Sector | Consumer Discretionary | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.3M | 57.1M |
| IPO Year | 2003 | 2018 |
| Metric | MCHX | YI |
|---|---|---|
| Price | $1.36 | $6.83 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 10.6K | ★ 14.4K |
| Earning Date | 03-25-2026 | 03-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 52.17 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $90,291,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.70 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.26 | $2.48 |
| 52 Week High | $2.30 | $11.17 |
| Indicator | MCHX | YI |
|---|---|---|
| Relative Strength Index (RSI) | 37.07 | 49.13 |
| Support Level | $1.35 | $6.75 |
| Resistance Level | $1.76 | $7.44 |
| Average True Range (ATR) | 0.06 | 0.36 |
| MACD | 0.01 | -0.12 |
| Stochastic Oscillator | 0.00 | 51.00 |
Marchex Inc provides AI-based conversational intelligence and analytics solutions that generate insights from customer communications data. The company's products support sales, marketing, and executive teams in analyzing customer interactions across communication channels and informing business decisions. It serves companies operating in business-to-business-to-consumer (B2B2C) markets across multiple industries like automotive, home services, healthcare, real estate, and advertising. The company operates in a single segment: conversational analytics and related solutions. The company generates the majority of revenue from its conversational intelligence product offerings. Geographically, it generates the maximum revenue from the United States.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.